Uganda is looking forward to start on the trials for the Covid 19 vaccine in November this year, an effort to fight the pandemic in the country.
The Vaccine known as Self-Replicating RNA is a product of the research innovation made by Uganda Virus Research Institute (UVRI) and Imperial College in the UK. The vaccine will undergo three different stages before it’s declared free to be used by the public according to the ministry of health.
According to Dr Musenero the permanent secretary in the office of the ministry of health the first trial will be conducted on 10 Ugandans to see how they will respond to the vaccine and its possible side effects on the human body. The rest of the trials will be done on about 100 to 200 people before the final stage of a random trial of between 1000 and 3000 people.
As of today, Uganda stands at 7530 Covid 19 cases and 73 deaths with 3647 recoveries.